Metformin seeks approval for first life extension drug trial
City AM - 09-Jul-2015Existing diabetes drug has been show to delay aging so researchers are now applying to the US Foo...
Previously the Live Forever Club — same community, now with a sharper mission for life extension
News provider covering latest business and finance news
For 16 years, City A.M. has served London’s professionals with the latest business news, markets information and analysis of the financial world.
The paper is distributed daily at more than 400 carefully chosen commuter hubs across London and the home counties, as well as 1,600 offices throughout the City, Canary Wharf and other areas of high business concentration, giving it a daily readership in excess of 399,000 professionals.
City A.M. is expanding its digital presence and has over 1.6m monthly users globally. It also has a number of luxury magazines in its portfolio including Bespoke, Living and Money,.
Visit website: http://www.cityam.com/
Details last updated 04-Feb-2019
Existing diabetes drug has been show to delay aging so researchers are now applying to the US Foo...